90309087 - DAOGEST

Information

  • Trademark
  • 90309087
  • Serial Number
    90309087
  • Registration Number
    6896062
  • Filing Date
    November 10, 2020
    4 years ago
  • Registration Date
    November 08, 2022
    2 years ago
  • Transaction Date
    November 08, 2022
    2 years ago
  • Status Date
    November 08, 2022
    2 years ago
  • Published for Opposition Date
    July 20, 2021
    3 years ago
  • Location Date
    October 05, 2022
    2 years ago
  • First Use Anywhere Date
    March 08, 2021
    3 years ago
  • First Use In Commerce Date
    March 08, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    SAITO, KIM TSUKIYO
  • Attorney Docket Number
    S25087
    Attorney Name
    LEIGH ANN LINDQUIST
    Law Office Assigned Location Code
    N60
  • Owners
Mark Drawing Code
5000
Mark Identification
DAOGEST
Case File Statements
  • DM0000: The mark consists of the stylized word "DAOgest".
  • GS0051: Diamine oxidase-based enzymes sold as an ingredient of pharmaceutical products and preparations for medical and veterinary use for the treatment of histamine intolerance and its associated symptoms, and modulation of histamine imbalances and assists in the control of histamine derived from the diet; sanitary sterilizing preparations for medical use; Diamine oxidase-based enzymes sold as an ingredient of dietetic food and dietetic preparations adapted for medical and veterinary use; Diamine oxidase-based enzymes sold as an ingredient of baby food; Diamine oxidase-based enzymes sold as an ingredient of food supplements for people and animals; Disinfectants; Diamine oxidase-based enzymes sold as an ingredient of diamine oxidase-based pharmaceuticals for the treatment of histamine intolerance and its associated symptoms, and modulation of histamine imbalances and assistance in the control of histamine derived from the diet; Diamine oxidase-based enzymes sold as an ingredient of diamine oxidase-based dietetic food and dietetic preparations adapted for medical use for the treatment of histamine intolerance and its associated symptoms, and modulation of histamine imbalances and assistance in the control of histamine derived from the diet; Diamine oxidase-based enzymes sold as an ingredient of diamine oxidase-based nutritional and food supplements for the treatment of histamine intolerance and its associated symptoms, and modulation of histamine imbalances and assistance in the control of histamine derived from the diet
Case File Event Statements
  • 11/8/2022 - 2 years ago
    39 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 11/8/2022 - 2 years ago
    38 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/6/2022 - 2 years ago
    37 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 10/5/2022 - 2 years ago
    36 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 10/5/2022 - 2 years ago
    35 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 10/5/2022 - 2 years ago
    34 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 10/5/2022 - 2 years ago
    33 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 10/5/2022 - 2 years ago
    32 - SU-EXAMINER'S AMENDMENT WRITTEN Type: SNEA
  • 9/14/2022 - 2 years ago
    31 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/14/2022 - 2 years ago
    30 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/14/2022 - 2 years ago
    29 - SU - NON-FINAL ACTION - WRITTEN Type: CNRT
  • 8/3/2022 - 2 years ago
    28 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/3/2022 - 2 years ago
    27 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/3/2022 - 2 years ago
    26 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/14/2022 - 2 years ago
    25 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/14/2022 - 2 years ago
    24 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/14/2022 - 2 years ago
    23 - SU - NON-FINAL ACTION - WRITTEN Type: CNRT
  • 2/15/2022 - 2 years ago
    22 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 1/27/2022 - 3 years ago
    21 - USE AMENDMENT FILED Type: IUAF
  • 2/14/2022 - 2 years ago
    20 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 1/27/2022 - 3 years ago
    19 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 9/14/2021 - 3 years ago
    18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/20/2021 - 3 years ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/20/2021 - 3 years ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/30/2021 - 3 years ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/11/2021 - 3 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/11/2021 - 3 years ago
    13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/11/2021 - 3 years ago
    12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/11/2021 - 3 years ago
    11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/11/2021 - 3 years ago
    10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 5/8/2021 - 3 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/8/2021 - 3 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/8/2021 - 3 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/19/2021 - 3 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/22/2021 - 3 years ago
    5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 3/18/2021 - 3 years ago
    4 - ASSIGNED TO LIE Type: ALIE
  • 1/8/2021 - 4 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 12/16/2020 - 4 years ago
    2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 11/13/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP